RBC Capital Starts Orexigen Therapeutics (OREX) at Outperform
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Rating Summary:
3 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
3 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
RBC Capital initiated coverage on Orexigen Therapeutics (NASDAQ: OREX) with an Outperform rating and a price target of $10.00.
For an analyst ratings summary and ratings history on Orexigen Therapeutics click here. For more ratings news on Orexigen Therapeutics click here.
Shares of Orexigen Therapeutics closed at $5.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- JPMorgan Starts COSCO SHIPPING Energy Transportation (1138:HK) at Overweight
- Deutsche Bank Starts BioMerieux (BIM:FP) (BMXMF) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
